Life sciences news
-
QbD Group requalifies as Best Managed Company
Friday May 13th 2022
Read more
-
Rejuvenate Biomed appoints life sciences leader Dr. Ajit Shetty as Chair of the Board of Directors to help guide international ambitions
Thursday May 12th 2022
Read more
-
Bone Therapeutics enters into exclusive reverse merger discussions with Medsenic
Thursday May 12th 2022
Read more
-
Augustine Therapeutics appoints Gerhard Koenig as Chairman of the Board, forms Clinical Advisory Board, and broadens therapeutic indications
Tuesday May 10th 2022
Read more
-
UCB presents efficacy and safety results for zilucoplan and rozanolixizumab in generalized myasthenia gravis
Tuesday May 10th 2022
Read more
-
Quality by Design (QbD) becomes QbD Group, consolidating its offerings to support the development of innovative life science products, “from idea to patient”
Monday May 9th 2022
Read more
-
Oxurion announces top-line results from Part A of Phase 2 INTEGRAL trial evaluating THR-687 for treatment of diabetic macular edema (DME)
Monday May 9th 2022
Read more
-
Ziphius Vaccines and Ghent University publish promising data from self-amplifying RNA platform in Molecular Therapy
Friday May 6th 2022
Read more
-
Your news here?
-
argenx announces positive Phase 3 data from ADVANCE trial of VYVGART® (efgartigimod alfa-fcab) in adults with primary immune thrombocytopenia
Thursday May 5th 2022
Read more
-
The European Spatial Biology Center (ESBC): State-of-the-art spatial biology services enabled at scale in Leuven
Thursday May 5th 2022
Read more
-
New study led by Memorial Sloan Kettering Cancer Center (NY, US) shows Idylla™ GeneFusion Assay enables more rapid screening of targetable fusions compared to routine methods
Wednesday May 4th 2022
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator